Michael Wourms is the SVP, Site Operations of Arranta Bio. Mr. Wourms has more than 10 years of experience working with biopharmaceutical manufacturing of advanced therapies including viral vectors, cell therapies, live biotherapeutics, and nucleic acids. During his career, he has held roles of increasing leadership responsibility across product development and GMP manufacturing of complex biologic drug substance and sterile injectable drug product. During his early career, Mike accumulated deep hands-on experience performing research, process development, and GMP manufacturing of drug substance and sterile drug product. Mike brings extensive experience leading R&D and GMP operations, facility start-ups, capacity expansions, and establishing new technology platforms for advanced therapies. Prior to Arranta, Michael held operational leadership roles with Elevate Bio and Brammer Bio where he had responsibility for establishing and leading GMP manufacturing operations. He holds a B.S. degree in microbiology & immunology and an M.S. in pharmacology & toxicology.